Classification of myeloproliferative neoplasms and chronic myeloproliferative disorders

被引:0
|
作者
Kreipe, Hans H. [1 ]
机构
[1] Hannover Med Sch, Inst Pathol, Carl Neuberg Str 1, D-30625 Hannover, Germany
来源
ONKOLOGE | 2019年 / 25卷 / 11期
关键词
Polycythemia vera; Primary Myelofibrosis; Essential thrombocytosis; Driver mutations; Progress; CHRONIC IDIOPATHIC MYELOFIBROSIS; ESSENTIAL THROMBOCYTHEMIA; U2AF1; MUTATIONS; LEUKEMIA; CALRETICULIN; IMATINIB; JAK2;
D O I
10.1007/s00761-019-0577-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Myeloproliferative neoplasms (MPN, chronic myeloproliferative disorders according to the former nomenclature) comprise chronic myeloid leukemia (CML), BCR-ABL positive CML, polycythemia vera (PV), primary myelofibrosis (PMF), essential thrombocythemia (ET), chronic eosinophilic leukemia (CEL) and chronic neutrophilic leukemia (CNL). The MPNs have a biphasic course in common with initial overproduction of one or more blood cell lineages, followed by hematopoietic insufficiency because of a blast crisis and/or bone marrow fibrosis. Classification and prognosis require a combined approach of morphological investigations, frequently including bone marrow histology and molecular pathological analysis with detection of characteristic driver mutations as well as the course of additional modulating genetic aberrations.
引用
收藏
页码:957 / 970
页数:14
相关论文
共 50 条
  • [41] Chronic Myeloproliferative Neoplasms: Some Remaining Challenges
    Mughal, Tariq I.
    Saglio, Giuseppe
    Van Etten, Richard A.
    [J]. HEMASPHERE, 2018, 2 (05):
  • [42] Aberrant proplatelet formation in chronic myeloproliferative neoplasms
    Muth, Michaela
    Buesche, Guntram
    Bock, Oliver
    Hussein, Kais
    Kreipe, Hans
    [J]. LEUKEMIA RESEARCH, 2010, 34 (11) : 1424 - 1429
  • [43] Cancer risk in chronic myeloproliferative neoplasms Response
    Frederiksen, Henrik
    Farkas, Dora Kormendine
    Christiansen, Christian Fynbo
    Hasselbalch, Hans Carl
    Sorensen, Henrik Toft
    [J]. BLOOD, 2012, 119 (16) : 3862 - 3863
  • [44] Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms
    Oyarzun, Cecilia P. Marin
    Heller, Paula G.
    [J]. FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [45] Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression
    Hahm, C.
    Huh, H. J.
    Mun, Y. C.
    Seong, C. M.
    Chung, W. S.
    Huh, J.
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2015, 37 (02) : 181 - 189
  • [46] HISTOLOGIC CRITERIA FOR CLASSIFICATION AND DIFFERENTIAL-DIAGNOSIS OF CHRONIC MYELOPROLIFERATIVE DISORDERS
    FRISCH, B
    BARTL, R
    BURKHARDT, R
    JAGER, K
    [J]. HAEMATOLOGIA, 1984, 17 (02) : 209 - 226
  • [47] Changing Concepts of Diagnostic Criteria of Myeloproliferative Disorders and the Molecular Etiology and Classification of Myeloproliferative Neoplasms: From Dameshek 1950 to Vainchenker 2005 and Beyond
    Michiels, Jan Jacques
    Berneman, Zwi
    Schroyens, Wilfried
    De Raeve, Hendrik
    [J]. ACTA HAEMATOLOGICA, 2015, 133 (01) : 36 - 51
  • [48] Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
    Buettner-Herold, Maike
    Sticht, Carsten
    Wiech, Thorsten
    Porubsky, Stefan
    [J]. HISTOPATHOLOGY, 2021, 78 (05) : 738 - 748
  • [49] The role of β-catenin in chronic myeloproliferative disorders
    Jauregui, Monica P.
    Sanchez, Steven R.
    Ewton, April A.
    Rice, Lawrence
    Perkins, Sherrie L.
    Dunphy, Cherie H.
    Chang, Chung-Che
    [J]. HUMAN PATHOLOGY, 2008, 39 (10) : 1454 - 1458
  • [50] UNCONTROLLED THROMBOCYTOSIS IN CHRONIC MYELOPROLIFERATIVE DISORDERS
    KESSLER, CM
    KLEIN, HG
    HAVLIK, RJ
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1982, 50 (01) : 157 - 167